1.The effect of pingyangmycin in the treatment of hemangioma in maxillofacial region: A report of 520 cases
Weidong SHOU ; Binfei YE ; Baiquan SHOU ; Mingyue XU ; Zhaoye MENG
Journal of Practical Stomatology 1995;0(04):-
Objective: To evaluaate the effect of pingyangmycin(PYM ) in the treatment of cavernous hemangioma, strawberry hemangioma and mixed hemangioma in the oro-maxillo-facial region. Methods:The medical records of 520 patients with hemangioma in oro-maxillo-facial region between January 1994 and January 2000 were reviewed. Pingyangmycin(
2.Pingyangmycin injection under suspension laryngoscopy for giant hemangioma at hypopharynx and laryngeal in 12 cases hemangioma at hypopharynx and laryngeal in 12 cases.
Lang GUO ; Shusen LIU ; Ping JIANG ; Weiwei HENG ; Weidong SHOU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(9):647-649
OBJECTIVE:
To explore the therapeutic methods and effect of pingyangmycin injection in huge hemangioma at Hypopharynx and laryngeal under suspension laryngoscopy.
METHOD:
To ananysize the medical records of 12 Patients with giant hemangioma at hypopharynx and laryngeal. Patients were underwent polysomnography before operation. Inseted the suspension laryngoscopy to pars laryngea by mouth to exposing the hemangioma under general anaesthesia, then injected Pingyangmycin by a long-tube needling (one time per three weeks, accumulated dose less than 50 mg).
RESULT:
Among all patients, ten were cured and two showed obvious improvement. The data of PSG after operation indicates that the symptom of anoxia of post-operation were significantly ameliorated than that of pre-operation, no recurrence occurred during one year follow-up of the hemangioma.
CONCLUSION
The methods of pingyangmycin injection under suspension laryngoscopic surgery is significantly enhanced clinical effect and improved the life quality of patients with huge hemangioma, which with low risk, high security, can ameliorating anoxia, complete cure, and is a ideal therapeutic measure.
Adult
;
Bleomycin
;
administration & dosage
;
analogs & derivatives
;
Female
;
Hemangioma
;
therapy
;
Humans
;
Hypopharynx
;
pathology
;
Laryngoscopy
;
Larynx
;
pathology
;
Male
;
Middle Aged
;
Treatment Outcome
;
Young Adult
3.Expression and clinical significance of serum angiopoietin-2 in patients with chronic heart failure
Haoyu WU ; Chunyan ZHANG ; Lei LIANG ; Congxia WANG ; Xiling SHOU ; Yan ZHANG ; Weidong MA ; Shan JIA ; Yang ZHENG ; Xiaohuan LIU
Journal of Xi'an Jiaotong University(Medical Sciences) 2016;37(3):336-338,348
Objective To investigate the expression of serum angiopoietin-2 (Ang-2 ) and its clinical significance in patients with chronic heart failure (CHF).Methods The levels of serum Ang-2,N-terminal pro-B-type natriuretic peptide (NT-proBNP)and left ventricular ejection fraction (LVEF)were detected in 1 1 3 patients with CHF,who were divided into four groups according to New York Heart Association (NYHA:class Ⅰ,n=3 2;Ⅱ,n=30;Ⅲ,n=26;Ⅳ,n=25).Another 20 healthy volunteers for physical check-up were chosen as the control group.Results With the change of cardiac function (from Ⅰ to Ⅳ),the levels of plasma Ang-2 and NT-proBNP were increased significantly (P<0.05 ).The level of serum Ang-2 was positively correlated with NT-proBNP (r=0.774,P<0.001),but negatively correlated with left ventricular ejection fraction (r=-0.725,P<0.001).Conclusion The level of serum Ang-2 has a significant correlation with the severity of heart failure.Ang-2 is expected to be used to predict and evaluate the severity of CHF.